
Robert E. Mosser
Examiner (ID: 16617, Phone: (571)272-4451 , Office: P/3714 )
| Most Active Art Unit | 3715 |
| Art Unit(s) | 3714, 3715, 3713, 3712 |
| Total Applications | 839 |
| Issued Applications | 347 |
| Pending Applications | 141 |
| Abandoned Applications | 372 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6637701
[patent_doc_number] => 20100173887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'BACTERICIDAL ANTI-MRSA ACTIVE PHARMACEUTICAL COMPOSITION CONTAINING CARBAPENEMS'
[patent_app_type] => utility
[patent_app_number] => 12/601259
[patent_app_country] => US
[patent_app_date] => 2008-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6098
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173887.pdf
[firstpage_image] =>[orig_patent_app_number] => 12601259
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/601259 | Bactericidal anti-MRSA active pharmaceutical composition containing carbapenems | May 13, 2008 | Issued |
Array
(
[id] => 5546761
[patent_doc_number] => 20090156638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'Uses of nordihydroguaiaretic acid (NDGA) and derivatives thereof in preventing transmission of sexually transmitted diseases'
[patent_app_type] => utility
[patent_app_number] => 12/152037
[patent_app_country] => US
[patent_app_date] => 2008-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12209
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20090156638.pdf
[firstpage_image] =>[orig_patent_app_number] => 12152037
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/152037 | Uses of nordihydroguaiaretic acid (NDGA) and derivatives thereof in preventing transmission of sexually transmitted diseases | May 11, 2008 | Abandoned |
Array
(
[id] => 12191623
[patent_doc_number] => 09895334
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-20
[patent_title] => 'Treatment of virally induced lesions'
[patent_app_type] => utility
[patent_app_number] => 12/598102
[patent_app_country] => US
[patent_app_date] => 2008-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12870
[patent_no_of_claims] => 85
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12598102
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/598102 | Treatment of virally induced lesions | Apr 29, 2008 | Issued |
Array
(
[id] => 4711739
[patent_doc_number] => 20080300265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'ANTIVIRAL DRUGS FOR TREATMENT OF ARENAVRUS INFECTION'
[patent_app_type] => utility
[patent_app_number] => 12/111778
[patent_app_country] => US
[patent_app_date] => 2008-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17489
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20080300265.pdf
[firstpage_image] =>[orig_patent_app_number] => 12111778
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/111778 | Antiviral drugs for treatment of arenavirus infection | Apr 28, 2008 | Issued |
Array
(
[id] => 4779451
[patent_doc_number] => 20080287449
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'AZA-TRIPEPTIDE HEPATITIS C SERINE PROTEASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/108647
[patent_app_country] => US
[patent_app_date] => 2008-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13556
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20080287449.pdf
[firstpage_image] =>[orig_patent_app_number] => 12108647
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/108647 | AZA-TRIPEPTIDE HEPATITIS C SERINE PROTEASE INHIBITORS | Apr 23, 2008 | Abandoned |
Array
(
[id] => 4675769
[patent_doc_number] => 20080213398
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Modified Azole Compounds as Antifungal and Antibacterial Agents'
[patent_app_type] => utility
[patent_app_number] => 12/108262
[patent_app_country] => US
[patent_app_date] => 2008-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5087
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213398.pdf
[firstpage_image] =>[orig_patent_app_number] => 12108262
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/108262 | Modified azole compounds as antifungal and antibacterial agents | Apr 22, 2008 | Issued |
Array
(
[id] => 6444800
[patent_doc_number] => 20100144678
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-10
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING BONE CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/595296
[patent_app_country] => US
[patent_app_date] => 2008-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9804
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20100144678.pdf
[firstpage_image] =>[orig_patent_app_number] => 12595296
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/595296 | COMPOSITIONS AND METHODS FOR TREATING BONE CANCER | Apr 8, 2008 | Abandoned |
Array
(
[id] => 7555552
[patent_doc_number] => 08067453
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-29
[patent_title] => 'Neurotrophin production/secretion promoting agent'
[patent_app_type] => utility
[patent_app_number] => 12/080461
[patent_app_country] => US
[patent_app_date] => 2008-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 36826
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/067/08067453.pdf
[firstpage_image] =>[orig_patent_app_number] => 12080461
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/080461 | Neurotrophin production/secretion promoting agent | Apr 2, 2008 | Issued |
Array
(
[id] => 5507941
[patent_doc_number] => 20090081148
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'PROTECTION OF KERATINOUS FIBERS USING CERAMIDES AND/OR GLYCOCERAMIDES'
[patent_app_type] => utility
[patent_app_number] => 12/058119
[patent_app_country] => US
[patent_app_date] => 2008-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8072
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081148.pdf
[firstpage_image] =>[orig_patent_app_number] => 12058119
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/058119 | Protection of keratinous fibers using ceramides and/or glycoceramides | Mar 27, 2008 | Issued |
Array
(
[id] => 6497052
[patent_doc_number] => 20100286125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'Hydroxamic acid derivatives of 4-phenyl 4-hydroxy, 4-phenyl 4-alkoxy and 4-phenyl 4-arylalkoxy butyric acid useful as therapeutic agents for treating anthrax poisoning'
[patent_app_type] => utility
[patent_app_number] => 12/079722
[patent_app_country] => US
[patent_app_date] => 2008-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23345
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286125.pdf
[firstpage_image] =>[orig_patent_app_number] => 12079722
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/079722 | Hydroxamic acid derivatives of 4-phenyl 4-hydroxy, 4-phenyl 4-alkoxy and 4-phenyl 4-arylalkoxy butyric acid useful as therapeutic agents for treating anthrax poisoning | Mar 27, 2008 | Issued |
Array
(
[id] => 4955461
[patent_doc_number] => 20080188485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-07
[patent_title] => 'PIPERIDINE DERIVATIVES USEFUL AS CCR5 ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/055900
[patent_app_country] => US
[patent_app_date] => 2008-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30212
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0188/20080188485.pdf
[firstpage_image] =>[orig_patent_app_number] => 12055900
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/055900 | Piperazine derivatives useful as CCR5 antagonists | Mar 25, 2008 | Issued |
Array
(
[id] => 7685058
[patent_doc_number] => 20100121083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'ANTI-VIRAL AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/532062
[patent_app_country] => US
[patent_app_date] => 2008-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4943
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20100121083.pdf
[firstpage_image] =>[orig_patent_app_number] => 12532062
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/532062 | ANTI-VIRAL AGENT | Mar 18, 2008 | Abandoned |
Array
(
[id] => 6615530
[patent_doc_number] => 20100099674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'METHOD AND MEANS FOR PREVENTING AND INHIBITING TYPE III SECRETION IN INFECTIONS CAUSED BY GRAM-NEGATIVE BACTERIA'
[patent_app_type] => utility
[patent_app_number] => 12/531397
[patent_app_country] => US
[patent_app_date] => 2008-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3071
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099674.pdf
[firstpage_image] =>[orig_patent_app_number] => 12531397
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/531397 | METHOD AND MEANS FOR PREVENTING AND INHIBITING TYPE III SECRETION IN INFECTIONS CAUSED BY GRAM-NEGATIVE BACTERIA | Mar 17, 2008 | Abandoned |
Array
(
[id] => 8690040
[patent_doc_number] => 08389568
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-03-05
[patent_title] => 'IDO inhibitors and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/528466
[patent_app_country] => US
[patent_app_date] => 2008-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6904
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12528466
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/528466 | IDO inhibitors and methods of use thereof | Mar 13, 2008 | Issued |
Array
(
[id] => 6327482
[patent_doc_number] => 20100197671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'PHENYL AMINO PYRIMIDINE COMPOUNDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/530610
[patent_app_country] => US
[patent_app_date] => 2008-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 32189
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20100197671.pdf
[firstpage_image] =>[orig_patent_app_number] => 12530610
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/530610 | Phenyl amino pyrimidine compounds and uses thereof | Mar 11, 2008 | Issued |
Array
(
[id] => 4753275
[patent_doc_number] => 20080161350
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'USE OF QUINOLINE DERIVATIVES WITH ANTI-INTEGRASE EFFECT AND APPLICATIONS THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/042628
[patent_app_country] => US
[patent_app_date] => 2008-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 2083
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20080161350.pdf
[firstpage_image] =>[orig_patent_app_number] => 12042628
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/042628 | USE OF QUINOLINE DERIVATIVES WITH ANTI-INTEGRASE EFFECT AND APPLICATIONS THEREOF | Mar 4, 2008 | Abandoned |
Array
(
[id] => 6538777
[patent_doc_number] => 20100204314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-12
[patent_title] => 'DRUG FOR TREATMENT OF INFLUENZA'
[patent_app_type] => utility
[patent_app_number] => 12/449909
[patent_app_country] => US
[patent_app_date] => 2008-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6698
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20100204314.pdf
[firstpage_image] =>[orig_patent_app_number] => 12449909
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/449909 | DRUG FOR TREATMENT OF INFLUENZA | Mar 2, 2008 | Abandoned |
Array
(
[id] => 4808171
[patent_doc_number] => 20080171749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => '1-Phenyl-1,2-Diaminoethane Derivatives As Modulators Of The Chemokine Receptor Activity'
[patent_app_type] => utility
[patent_app_number] => 12/038344
[patent_app_country] => US
[patent_app_date] => 2008-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12078
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171749.pdf
[firstpage_image] =>[orig_patent_app_number] => 12038344
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/038344 | 1-Phenyl-1,2-Diaminoethane Derivatives As Modulators Of The Chemokine Receptor Activity | Feb 26, 2008 | Abandoned |
Array
(
[id] => 4751898
[patent_doc_number] => 20080159971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'USE OF DHEA OR PRECURSORS OR METABOLIC DERIVATIVES THEREOF AS A DEPIGMENTING AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/037413
[patent_app_country] => US
[patent_app_date] => 2008-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3806
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20080159971.pdf
[firstpage_image] =>[orig_patent_app_number] => 12037413
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/037413 | USE OF DHEA OR PRECURSORS OR METABOLIC DERIVATIVES THEREOF AS A DEPIGMENTING AGENT | Feb 25, 2008 | Abandoned |
Array
(
[id] => 4728087
[patent_doc_number] => 20080207631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'METHODS FOR THE TREATMENT AND PREVENTION OF NEURODEGENERATIVE CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/037442
[patent_app_country] => US
[patent_app_date] => 2008-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2442
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20080207631.pdf
[firstpage_image] =>[orig_patent_app_number] => 12037442
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/037442 | METHODS FOR THE TREATMENT AND PREVENTION OF NEURODEGENERATIVE CONDITIONS | Feb 25, 2008 | Abandoned |